These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 31369124)

  • 21. Two-Sample Multivariable Mendelian Randomization Analysis Using R.
    Rasooly D; Peloso GM
    Curr Protoc; 2021 Dec; 1(12):e335. PubMed ID: 34936225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A data-adaptive method for investigating effect heterogeneity with high-dimensional covariates in Mendelian randomization.
    Tian H; Tom BDM; Burgess S
    BMC Med Res Methodol; 2024 Feb; 24(1):34. PubMed ID: 38341532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis.
    Yuan S; Chen J; Ruan X; Sun Y; Zhang K; Wang X; Li X; Gill D; Burgess S; Giovannucci E; Larsson SC
    Elife; 2023 Feb; 12():. PubMed ID: 36727839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.
    Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR
    Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing concordance of instrumental variable effects in generalized linear models with application to Mendelian randomization.
    Dai JY; Chan KC; Hsu L
    Stat Med; 2014 Oct; 33(23):3986-4007. PubMed ID: 24863158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditional inference in cis-Mendelian randomization using weak genetic factors.
    Patel A; Gill D; Newcombe P; Burgess S
    Biometrics; 2023 Dec; 79(4):3458-3471. PubMed ID: 37337418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of causality between serum gamma-glutamyltransferase and type 2 diabetes mellitus using publicly available data: a Mendelian randomization study.
    Noordam R; Smit RA; Postmus I; Trompet S; van Heemst D
    Int J Epidemiol; 2016 Dec; 45(6):1953-1960. PubMed ID: 28031309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approximation of bias and mean-squared error in two-sample Mendelian randomization analyses.
    Deng L; Zhang H; Song L; Yu K
    Biometrics; 2020 Jun; 76(2):369-379. PubMed ID: 31651042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates.
    Taylor AE; Davies NM; Ware JJ; VanderWeele T; Smith GD; Munafò MR
    Econ Hum Biol; 2014 Mar; 13(100):99-106. PubMed ID: 24388127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Mendelian randomization to investigate a possible causal relationship between adiposity and increased bone mineral density at different skeletal sites in children.
    Kemp JP; Sayers A; Smith GD; Tobias JH; Evans DM
    Int J Epidemiol; 2016 Oct; 45(5):1560-1572. PubMed ID: 27215616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation.
    Dixon P; Davey Smith G; von Hinke S; Davies NM; Hollingworth W
    Pharmacoeconomics; 2016 Nov; 34(11):1075-1086. PubMed ID: 27484822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mendelian randomization: genetic anchors for causal inference in epidemiological studies.
    Davey Smith G; Hemani G
    Hum Mol Genet; 2014 Sep; 23(R1):R89-98. PubMed ID: 25064373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the current state of Mendelian randomization studies: a protocol for a systematic review on methodological and clinical aspects using neurodegenerative disorders as outcome.
    Grover S; Del Greco M F; König IR
    Syst Rev; 2018 Sep; 7(1):145. PubMed ID: 30249280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Power and sample size calculations for Mendelian randomization studies using one genetic instrument.
    Freeman G; Cowling BJ; Schooling CM
    Int J Epidemiol; 2013 Aug; 42(4):1157-63. PubMed ID: 23934314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constrained instruments and their application to Mendelian randomization with pleiotropy.
    Jiang L; Oualkacha K; Didelez V; Ciampi A; Rosa-Neto P; Benedet AL; Mathotaarachchi S; Richards JB; Greenwood CMT;
    Genet Epidemiol; 2019 Jun; 43(4):373-401. PubMed ID: 30635941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mendelian randomization: use of genetics to enable causal inference in observational studies.
    Verduijn M; Siegerink B; Jager KJ; Zoccali C; Dekker FW
    Nephrol Dial Transplant; 2010 May; 25(5):1394-8. PubMed ID: 20190244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization.
    Staley JR; Burgess S
    Genet Epidemiol; 2017 May; 41(4):341-352. PubMed ID: 28317167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization.
    Sanderson E; Spiller W; Bowden J
    Stat Med; 2021 Nov; 40(25):5434-5452. PubMed ID: 34338327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
    Rees JMB; Wood AM; Burgess S
    Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.
    Sanderson E; Davey Smith G; Windmeijer F; Bowden J
    Int J Epidemiol; 2019 Jun; 48(3):713-727. PubMed ID: 30535378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.